Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to -$6.4 million.

  • Angiodynamics' Income from Continuing Operations rose 4086.42% to -$6.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$27.7 million, marking a year-over-year increase of 8766.92%. This contributed to the annual value of -$34.0 million for FY2025, which is 8156.05% up from last year.
  • As of Q4 2025, Angiodynamics' Income from Continuing Operations stood at -$6.4 million, which was up 4086.42% from -$10.9 million recorded in Q3 2025.
  • Angiodynamics' 5-year Income from Continuing Operations high stood at $45.9 million for Q3 2023, and its period low was -$187.7 million during Q1 2024.
  • Its 5-year average for Income from Continuing Operations is -$16.9 million, with a median of -$9.0 million in 2022.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first surged by 45284.53% in 2023, then plummeted by 187929.36% in 2024.
  • Quarter analysis of 5 years shows Angiodynamics' Income from Continuing Operations stood at -$8.4 million in 2021, then decreased by 1.62% to -$8.5 million in 2022, then crashed by 242.3% to -$29.0 million in 2023, then surged by 63.03% to -$10.7 million in 2024, then skyrocketed by 40.86% to -$6.4 million in 2025.
  • Its last three reported values are -$6.4 million in Q4 2025, -$10.9 million for Q3 2025, and -$6.0 million during Q2 2025.